Eyes On Eyecare Glance logo
Subscribe
Latest StoriesBusinessLegalPipelineResearchEventsProducts
Clinical ArticlesOcular SurfaceContact LensesGlaucomaRetinaPediatricsSEE MORE »
JobsOptometrist JobsOphthalmologist JobsOptician & Technician JobsHiring Services for EmployersSEE ALL JOBS »
Virtual EventsUpcoming Events
Eyes On Eyecare Glance logo
Stories
BusinessLegalPipelineResearchEventsProducts
Archives
See All Stories
Resources
ReportsCheat SheetsUltimate GuidesCalculators & Tools
See All Resources
EventsCoursesJobs
Search Eyecare JobsHiring Services for Employers
  • Organizations: Théa Pharma, Inc.
Patient studies show iVIZIA lubricant eye drops provide relief for all forms of dry eye
Products

Patient studies show iVIZIA lubricant eye drops provide relief for all forms of dry eye

Real-world research reveals that patients experience immediate relief lasting up to 8 hours with iVIZIA Lubricant Eye Drops.
Théa introduces new IYUZEH patient resources
Products

Théa introduces new IYUZEH patient resources

New brochure and revamped website target patient-facing information and education—including a simplified process for prescription filling
IYUZEH launches in the United States
Products

IYUZEH launches in the United States

Preservative-free formulation targets elevated IOP in OAG and OHT patients.
Preservative Freedom Coalition is targeting ocular surface awareness
Research

Preservative Freedom Coalition is targeting ocular surface awareness

Launched by Théa Pharma, the organization advocates for improved patient outcomes and ensuring access to safe and effective preservative-free treatment options.
Akorn Pharma recalls 70+ drugs from the US market
Products

Akorn Pharma recalls 70+ drugs from the US market

Company has ceased operations and shut down all facilities after filing for Chapter 7 bankruptcy in February 2023. 
Comparison study finds similar, positive profiles in Iyuzeh and Xalatan
Research

Comparison study finds similar, positive profiles in Iyuzeh and Xalatan

Pivotal trial notes clinically meaningful reduction of IOP in Iyuzeh.
Closing out 2022 with another FDA approval – Weekly Glance
Products

Closing out 2022 with another FDA approval – Weekly Glance

The FDA has just approved Iyuzeh.
FDA approves Théa Pharma’s Iyuzeh for glaucoma
Pipeline

FDA approves Théa Pharma’s Iyuzeh for glaucoma

The new approval targets patients with elevated IOP in OAG and ocular hypertension.
Eyes On Eyecare logoSan Diego, CA+1 858-246-7066
Thank you to the Eyes On Eyecare Site Sponsor Astellas
Read our reviews on Google
Hiring ServicesSearch for JobsHiring Services for EmployersPost an Eyecare JobEyecare RecruitingPricingJob Sitemap
Learn MoreAbout UsContact UsNewsroomEditorial Policy
Clinical ArticlesOcular SurfaceContact LensGlaucomaRetinaNeuroLow Vision
Join The TeamCareersEditorial BoardBecome a Writer
Career ArticlesPersonal FinancePractice ManagementOptometry StudentsNew GraduateResidencySalary & Benefits
EventsEvent Schedule

Advertising, Media Kit, & Partnerships

Eyes On Eyecare is currently distributing our 2025 media kit and Eyes On event prospectuses. Contact us to learn more about available opportunities - spaces are limited.

Media KitEvent Prospectus
We're Hiring!

Do you work in the eyecare industry? Check out our open positions!

Open Positions
Eyes On Eyecare:
Optometry:
Ophthalmology:
Glance:
© 2025 Eyes On Eyecare®. All rights reserved.
Privacy PolicyTerms of Service